Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-07-03T14:43:29.620Z Has data issue: false hasContentIssue false

Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women

Published online by Cambridge University Press:  25 July 2019

Alan Fappi
Affiliation:
Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA
Bettina Mittendorfer*
Affiliation:
Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA
*
*Corresponding author: Bettina Mittendorfer, email mittendb@wustl.edu
Rights & Permissions [Opens in a new window]

Abstract

CVD affect about one-third of the population and are the leading cause of mortality. The prevalence of CVD is closely linked to the prevalence of obesity because obesity is commonly associated with metabolic abnormalities that are important risk factors for CVD, including insulin resistance, pre-diabetes, and type-2 diabetes, atherosclerotic dyslipidaemia, endothelial dysfunction and hypertension. Women have a more beneficial traditional CVD risk profile (lower fasting plasma glucose, less atherogenic lipid profile) and a lower absolute risk for CVD than men. However, the relative risk for CVD associated with hyperglycaemia and dyslipidaemia is several-fold higher in women than in men. The reasons for the sex differences in CVD risk associated with metabolic abnormalities are unclear but could be related to differences in the mechanisms that cause hyperglycaemia and dyslipidaemia in men and women, which could influence the pathogenic processes involved in CVD. In the present paper, we review the influence of a person's sex on key aspects of metabolism involved in the cardiometabolic disease process, including insulin action on endogenous glucose production, tissue glucose disposal, and adipose tissue lipolysis, insulin secretion and insulin plasma clearance, postprandial glucose, fatty acid, and triglyceride kinetics, hepatic lipid metabolism and myocardial substrate use. We conclude that there are marked differences in many aspects of metabolism in men and women that are not all attributable to differences in the sex hormone milieu. The mechanisms responsible for these differences and the clinical implications of these observations are unclear and require further investigation.

Type
Conference on ‘Inter-individual differences in the nutrition response: from research to recommendations’
Copyright
Copyright © The Authors 2019

CVD, including atherosclerosis, hypertension, myocardial infarction, stroke and heart failure, affect about 10 % of young and middle-aged (<65 years) and about 30 % of older (≥65 years) adults and are the leading causes of mortality, accounting for >25 % of all deaths(1Reference Blackwell and Villarroel3). More than 80 % of CVD-related deaths are due to IHD and stroke(Reference Blackwell and Villarroel3). The prevalence of CVD is closely linked to the prevalence of obesity because obesity is commonly associated with metabolic abnormalities that are important risk factors for CVD, including insulin resistance, pre-diabetes, and type-2 diabetes (T2D), atherosclerotic dyslipidaemia, endothelial dysfunction and hypertension(Reference Klein, Wadden and Sugerman4Reference Nordestgaard, Benn and Schnohr13). Insulin is a key regulator of glucose and lipid metabolism and also regulates sympathetic nerve activity and endothelial function; accordingly, resistance to the effects of insulin is a key pathogenic mechanism involved in CVD(Reference Laakso and Kuusisto14). In addition, increases in plasma glucose and TAG per se are directly involved in causing the cellular pathogenic changes associated with hypertension and atherosclerosis(Reference Reusch and Wang15,Reference Miller, Stone and Ballantyne16) .

Premenopausal women have a more beneficial traditional CVD risk profile (lower fasting plasma glucose(Reference Menke, Rust and Savage17Reference Flanagan, Holt and Owens22) and less atherogenic lipid profile, characterised by lower plasma TAG and Apo-B containing particles, higher HDL-cholesterol, and more large and fewer small HDL particles(Reference Magkos, Mohammed and Mittendorfer19,Reference Pascot, Lemieux and Bergeron23) ) and a lower absolute risk for CVD than men. The observed sex differences in the metabolic CVD risk profile are attributed to the sex hormone milieu, particularly the protective effect of oestradiol, but it is becoming clear that chronological age per se has a major and possibly greater influence on cardiometabolic function in women than menopause(Reference Wang, Magkos and Mittendorfer24Reference Matthews, Crawford and Chae28). In addition, the relative risk for CVD associated with hyperglycaemia and dyslipidaemia is several-fold higher in women than in men(Reference Castelli5,Reference Abdel-Maksoud, Eckel and Hamman7,Reference Kannel and McGee10,Reference Wei, Gaskill and Haffner12,Reference Peters, Huxley and Woodward29Reference Sone, Tanaka and Tanaka33) . A meta-analysis of sixty four studies, including a total of 858 507 people, found the relative risk for CVD associated with T2D is about 45 % greater in women than in men(Reference Peters, Huxley and Woodward29); another, smaller meta-analysis, which focused on young and middle-aged (<60 years) adults only, found the relative risk for CVD associated with T2D is approximately three times as high in women than men(Reference Kalyani, Lazo and Ouyang30). Moreover, women with atherosclerotic dyslipidaemia (hypertriglyceridaemia and/or low HDL-cholesterol) have a two to four times greater risk for CVD than women with normal plasma lipids whereas atherosclerotic dyslipidaemia increases the risk for CVD by only 25–50 % in men(Reference Castelli5,Reference Abdel-Maksoud, Eckel and Hamman7) . The reasons for the sex differences in absolute CVD risk and CVD risk associated with increased glucose and TAG concentrations are unclear but could be related to differences in the mechanisms that cause hyperglycaemia and dyslipidaemia in men and women, which could influence the pathogenic processes involved in CVD. For example, the CVD risk associated with increased plasma TAG concentration is not simply determined by the total amount of TAG but dependent on the number of circulating TAG-containing lipoprotein particles at any given TAG concentration (i.e. lots of small TAG-poor v. few large, TAG-rich particles), and the T2D risk associated with impaired glucose tolerance depends on the shape of the plasma glucose profile after glucose ingestion, which is likely determined by variations in insulin secretion, plasma clearance and target tissue action(Reference Stock34Reference Trico, Natali and Arslanian40). In the present paper, we will review and highlight important differences in insulin kinetics and action, basal and postprandial glucose and lipid metabolism and myocardial substrate use between men and women.

Regulation of plasma glucose and TAG concentrations

Plasma glucose concentration is maintained by a balance between hepatic, and to a lesser extent, renal glucose production, meal glucose appearance in plasma and tissue glucose uptake. Insulin is a major regulator of endogenous glucose production and tissue glucose uptake (see(Reference Petersen and Shulman41Reference Petersen, Vatner and Shulman43) for excellent and detailed reviews). Insulin suppresses endogenous glucose production, both by acting directly on hepatocytes, and indirectly by inhibiting glucagon production and adipose tissue lipolysis(Reference Petersen, Vatner and Shulman43). Endogenous glucose production is very sensitive to the inhibitory effect of insulin and small increases in plasma insulin above basal values are sufficient to completely suppress it(Reference Kolterman, Insel and Saekow44Reference Rizza, Mandarino and Gerich46). Insulin stimulates tissue (predominantly muscle) glucose uptake in a dose-dependent manner and the maximal stimulatory effect of insulin on glucose disposal far exceeds the normal postprandial rise in plasma insulin(Reference Kolterman, Insel and Saekow44). Insulin is also a potent inhibitor of adipose tissue lipolysis and fatty acid release into plasma, and small increases in plasma insulin above basal values are sufficient to completely suppress it(Reference Conte, Fabbrini and Kars45,Reference Jensen and Nielsen47,Reference Jensen, Caruso and Heiling48) . Insulin also regulates hepatic TAG synthesis and secretion, both directly and indirectly by regulating adipose tissue lipolysis. Insulin stimulates hepatic de novo lipogenesis (DNL), inhibits VLDL-particle (Apo-B-100) and TAG secretion, and regulates the availability of adipose-derived fatty acids for hepatic TAG synthesis(Reference Petersen and Shulman41,Reference Sparks, Sparks and Adeli49) . In healthy people, insulin secretion, plasma insulin clearance and insulin sensitivity are tightly coordinated and both insulin secretion and insulin clearance often change simultaneously in opposite directions to compensate for changes in insulin sensitivity; relative insulin insufficiency due to an imbalance among insulin secretion, plasma clearance and sensitivity causes an increase in plasma glucose, fatty acid and TAG concentrations, and ultimately pre-diabetes, T2D and atherosclerotic dyslipidaemia(Reference Kim and Reaven50Reference Kahn, Prigeon and McCulloch52).

Basal plasma glucose concentration and flux in men and women

Plasma glucose concentration after an overnight fast is generally slightly (about 10 %) lower in women than in men(Reference Menke, Rust and Savage17Reference Flanagan, Holt and Owens22,Reference Arner and Ryden53) , but it is unclear whether this is due to less glucose production or more efficient plasma clearance in women than in men. The results from studies that evaluated basal endogenous glucose production are equivocal. In most studies basal endogenous glucose production, expressed per kg body weight or per kg fat-free mass, was not different in men and women, irrespective of adiposity status and age(Reference Hoeg, Sjoberg and Jeppesen54Reference Yeo, Hays and Dennis62). However, in some studies, basal endogenous glucose production, expressed per kg body weight or fat-free mass was less(Reference Anderwald, Gastaldelli and Tura18,Reference Honka, Latva-Rasku and Bucci63) and in others it was greater(Reference Basu, Dalla Man and Campioni64,Reference Tran, Jacot-Descombes and Lecoultre65) in women compared with age-matched men. The reasons for the differences in results among studies are unclear but are likely related to differences in the prevailing plasma insulin concentration (because insulin is a potent inhibitor of endogenous glucose production(Reference Conte, Fabbrini and Kars45)) and the duration of fasting, which affects hepatic glucose production differently in men and women(Reference Mittendorfer, Horowitz and Klein55,Reference Soeters, Sauerwein and Groener66) .

Basal plasma NEFA concentration and flux in men and women

Plasma NEFA concentration after an overnight fast is generally greater in women than men(Reference Arner and Ryden53,Reference Karpe, Dickmann and Frayn67Reference Mittendorfer, Yoshino and Patterson69) . The difference in NEFA concentration is largely due to the greater fat mass relative to fat-free mass, not differences in adipose tissue lipolytic activity and/or plasma clearance rate (reviewed later), in women than in men. We measured NEFA appearance rate in plasma, an index of adipose tissue lipolytic activity(Reference Mittendorfer, Liem and Patterson70), in lean, overweight and obese (including severely obese) men and women and found basal NEFA appearance rate in plasma, is directly related to fat mass, and the relationship between fat mass and NEFA appearance in plasma is not different in men and women(Reference Mittendorfer, Magkos and Fabbrini68). However, NEFA appearance rate in relationship to fat-free mass, or unit of plasma volume, or resting energy expenditure is approximately 50 % greater in women than in men(Reference Mittendorfer, Magkos and Fabbrini68,Reference Nielsen, Guo and Albu71,Reference Magkos, Patterson and Mohammed72) because women have more fat mass than men for any given amount of fat-free mass(Reference Gallagher, Heymsfield and Heo73), and fat-free mass is the primary determinant of resting energy expenditure(Reference Oshima, Miyauchi and Kawano74,Reference Cunningham75) .

Insulin action on glucose metabolism in men and women

Potential sex differences in insulin action on glucose metabolism have been evaluated by using the homoeostasis model assessment of insulin resistance (e.g.(Reference Guerra, Fuentes and Delgado-Guerra76,Reference Sung, Choi and Gwon77) ), the oral glucose tolerance test (OGTT) (e.g.(Reference Anderwald, Gastaldelli and Tura18,Reference Sumner, Kushner and Sherif78,Reference Faerch, Pacini and Nolan79) ), the intravenous glucose tolerance test (IVGTT) (e.g.(Reference Clausen, Borch-Johnsen and Ibsen21,Reference Flanagan, Holt and Owens22) ) and the gold-standard hyperinsulinaemic-euglycaemic clamp technique, with or without simultaneous glucose tracer infusion (e.g.(Reference Anderwald, Gastaldelli and Tura18,Reference Jensen and Nielsen47,Reference Hoeg, Sjoberg and Jeppesen54,Reference Ter Horst, Gilijamse and de Weijer57,Reference Frias, Macaraeg and Ofrecio58,Reference Chan, Chooi and Ding80 Reference Nuutila, Knuuti and Maki83)). We focus on the results from studies that used the hyperinsulinaemic-euglycaemic clamp procedure in conjunction with glucose tracers (stable isotope- or radio-labelled) to distinguish the effects of insulin on glucose production and glucose disposal (not those that only report the M-value, i.e. the glucose infusion rate during the clamp) and those that used the arterio-venous balance technique or dynamic positron emission tomography imaging to provide a direct measure of tissue glucose uptake rates. The homoeostasis model assessment of insulin resistance and the IVGTT-derived insulin sensitivity indices do not provide direct information about the effect of insulin on organ-specific glucose kinetics and the OGTT provides a standard 75 g dose of glucose to subjects regardless of body size, which makes the interpretation of the results difficult because women are generally smaller than men(Reference Faerch, Pacini and Nolan79,Reference Rathmann, Strassburger and Giani84,Reference Sicree, Zimmet and Dunstan85) .

Insulin action on endogenous glucose production

Endogenous glucose production is very sensitive to changes in plasma insulin and even small increases in plasma insulin concentration above values observed after an overnight fast can almost completely inhibit it(Reference Conte, Fabbrini and Kars45,Reference DeFronzo, Jacot and Jequier86) . A study that used a relatively low-dose insulin infusion rate that sub-maximally suppressed endogenous glucose production found endogenous glucose production was more sensitive to the inhibitory effect of insulin in women than men (greater relative suppression in women)(Reference Ter Horst, Gilijamse and de Weijer57). Several other studies evaluated the effects of higher (near maximally suppressive) doses of insulin on endogenous glucose production and found near maximally suppressed endogenous glucose production rates were not different in men and women(Reference Anderwald, Gastaldelli and Tura18,Reference Hoeg, Sjoberg and Jeppesen54,Reference Frias, Macaraeg and Ofrecio58) .

Insulin action on glucose disposal

Comparing whole body glucose disposal rates in men and women is difficult because of differences in body size and body composition in men and women. In healthy lean men, skeletal muscle accounts for the majority (>75 %) of whole body insulin-stimulated glucose disposal(Reference DeFronzo, Jacot and Jequier86,Reference Yki-Jarvinen, Young and Lamkin87) . However, both muscle and adipose tissue are highly sensitive to insulin(Reference Dadson, Landini and Helmio88Reference Williams, Price and Kelley90) and insulin-stimulated tissue glucose uptake rates in various adipose tissue depots range from 25 to >50 % the rates measured in muscle(Reference Honka, Latva-Rasku and Bucci63). Accordingly, the contribution of adipose tissue to total (whole body) glucose disposal depends on a person's adiposity. Whole body insulin-stimulated glucose disposal rate expressed per kg fat-free or lean body mass and adjusted for plasma insulin concentration was often not different in men or age-matched (young or older) women(Reference Jensen and Nielsen47,Reference Ter Horst, Gilijamse and de Weijer57,Reference Boirie, Gachon and Cordat81) but glucose uptake rate per leg lean mass (arterio-venous-balance technique) or uptake into muscle (assessed by using dynamic positron emission tomography imaging) was greater in lean women than in lean age-matched men(Reference Hoeg, Sjoberg and Jeppesen54,Reference Hoeg, Roepstorff and Thiele82,Reference Nuutila, Knuuti and Maki83) .

NEFA-induced insulin resistance of glucose metabolism in men and women

Plasma NEFA are important negative regulators of insulin action in liver and muscle. An experimentally-induced (intravenous lipid and heparin infusion) increase in plasma NEFA concentration before and during a hyperinsulinaemic-euglycaemic clamp impairs insulin action in liver and muscle in a dose-dependent manner(Reference Boden, Chen and Ruiz91Reference Belfort, Mandarino and Kashyap94). The adverse effect of NEFA on insulin action lasts for almost 4 h after cessation of lipid infusion(Reference Gormsen, Nielsen and Jessen95). The observed greater insulin sensitivity of both endogenous glucose production(Reference Ter Horst, Gilijamse and de Weijer57) and muscle glucose disposal(Reference Hoeg, Sjoberg and Jeppesen54,Reference Hoeg, Roepstorff and Thiele82,Reference Nuutila, Knuuti and Maki83) in women compared with men is therefore intriguing considering basal NEFA release from adipose tissue in relationship to fat-free mass is markedly greater in women than in men(Reference Mittendorfer, Magkos and Fabbrini68,Reference Nielsen, Guo and Albu71,Reference Magkos, Patterson and Mohammed72) . Several studies therefore tested the susceptibility of men and women to NEFA-induced insulin resistance. In some studies, women were less susceptible to NEFA-induced insulin resistance of glucose disposal(Reference Hoeg, Sjoberg and Jeppesen54,Reference Frias, Macaraeg and Ofrecio58) , whereas others reported no sex difference in NEFA-mediated insulin resistance(Reference Belfort, Mandarino and Kashyap94,Reference Vistisen, Hellgren and Vadset96) ; however, this could have been due to statistical power because a trend for a lower impairment in women than in men (46 v. 60 % impairment) was observed(Reference Vistisen, Hellgren and Vadset96). Only one study evaluated the effect of increased plasma NEFA concentration on insulin-mediated suppression of endogenous glucose production and found NEFA impaired it similarly in men and women(Reference Frias, Macaraeg and Ofrecio58).

Insulin action on adipose tissue lipolysis in men and women

Adipose tissue is very sensitive to the antilipolytic effect of insulin(Reference Jensen, Caruso and Heiling48), so even small differences in plasma insulin concentration can have marked effects on NEFA appearance in plasma. The results from studies that evaluated the effect of sex on insulin-mediated suppression of NEFA release into the circulation are inconsistent and difficult to interpret because different doses of insulin were used and plasma insulin concentrations were either not reported or markedly (about 30 %) different in men and women(Reference Jensen and Nielsen47,Reference Shadid, Kanaley and Sheehan97,Reference Millstein, Pyle and Bergman98) . However, one of these studies evaluated the dose–response relationship between plasma insulin concentration and NEFA rate of appearance in plasma in lean and overweight and obese men and women and found the half-maximum effective insulin concentration was not different in men and women but greater in obese than non-obese subjects(Reference Jensen and Nielsen47), suggesting no sex differences in insulin sensitivity of adipose tissue lipolysis but obesity-associated insulin-resistance in both men and women.

Insulin secretion in men and women

A large cohort study that included 380 healthy young subjects found plasma C-peptide concentration (an index of insulin secretion) after an overnight fast was greater in women than men(Reference Clausen, Borch-Johnsen and Ibsen21). Potential sex differences in glucose-stimulated insulin secretion have been evaluated by using both IVGTT and OGTT. During the IVGTT, a body weight-adjusted dose of glucose is provided, whereas the same standard dose of glucose (75 g) is given to everyone during the OGTT, which makes the interpretation of the results from OGTT difficult, because women are generally smaller than men(Reference Faerch, Pacini and Nolan79,Reference Rathmann, Strassburger and Giani84,Reference Sicree, Zimmet and Dunstan85) . The acute C-peptide response to an intravenous glucose challenge was not different in men and age-matched women(Reference Clausen, Borch-Johnsen and Ibsen21), but the acute insulin response was greater in women than men(Reference Clausen, Borch-Johnsen and Ibsen21,Reference Flanagan, Holt and Owens22) , suggesting similar glucose-induced insulin secretion but impaired insulin clearance in women compared with men (reviewed in more detail later). The interpretation of the results from studies that evaluated insulin secretion after mixed meal ingestion(Reference Basu, Dalla Man and Campioni64,Reference Chan, Chooi and Ding80) is complicated because different meals were used in different studies and meal energy and carbohydrate contents were not always adjusted for differences in body weight and energy expenditure in men and women. One study provided a body weight adjusted meal (41·84 kJ/kg and 1·2 g dextrose/kg) to both young and older men and women(Reference Basu, Dalla Man and Campioni64) and found the early rise in plasma C-peptide was not different in women and men, but women had slightly higher C-peptide concentrations during the later postprandial period (about 60 min after starting the meal).

Insulin clearance in men and women

The effect of sex on plasma insulin clearance is unclear because of conflicting results from different studies. A study that used the hyperinsulinaemic-euglycaemic pancreatic clamp technique in conjunction with arterial and hepatic vein blood sampling in young and older adults found whole body insulin clearance was greater in women than in men, and this was due to greater non-splanchnic insulin clearance in women whereas hepatic/splanchnic insulin clearance was lower in women than in men(Reference Jensen, Nielsen and Gupta99). Another study reported impaired steady-state insulin clearance during a hyperinsulinaemic-euglycaemic clamp in women compared with men, but insulin clearance was calculated as the insulin infusion rate divided by plasma insulin concentration(Reference Chan, Chooi and Ding80), which ignores residual endogenous insulin secretion during the clamp(Reference Waldhausl, Gasic and Bratusch-Marrain100). Studies that used a mathematical modelling approach to estimate whole body and regional plasma insulin clearance after mixed meal ingestion found postprandial non-splanchnic insulin clearance was greater in young Caucasian women than in men and splanchnic insulin clearance was significantly less or tended to be less in women than in men(Reference Basu, Dalla Man and Campioni64); however, in young Asian and older Caucasian subjects, plasma insulin clearance rates were not different in women and men(Reference Basu, Dalla Man and Campioni64,Reference Chan, Chooi and Ding80) . Data obtained during an IVGTT suggest impaired insulin clearance in women compared with men because the acute C-peptide response, which provides a measure of insulin secretion, was not different in men and women but insulin concentration was greater in women than in men(Reference Clausen, Borch-Johnsen and Ibsen21).

Postprandial glucose kinetics in men and women

Postprandial glucose kinetics in young and older men and women were evaluated by using a triple tracer mixed meal metabolic testing protocol(Reference Basu, Dalla Man and Campioni64). The meal provided 41·84 kJ/kg and contained 1·2 g dextrose/kg. Endogenous glucose production was rapidly and nearly completely suppressed during the first 60 min after meal ingestion and then returned to basal values in both men and women (both young and old). However, meal glucose appearance in plasma was faster in women than in men (both young and old). Differences in glucose absorption in men and women have also been observed during an OGTT(Reference Anderwald, Gastaldelli and Tura18), but the results cannot be directly compared with the meal test or among men and women because both men and women received 75 g glucose during the OGTT, so women received much more glucose relative to their body weight and metabolic rate than men.

Postprandial fatty acid kinetics in men and women

Postprandial endogenous and meal fatty acid appearance in plasma in men and pre-menopausal women has been evaluated by using a dual tracer (oral and intravenous) mixed meal testing protocol(Reference Jensen101). Meal ingestion suppressed the NEFA rate of appearance in plasma rapidly and nearly completely for almost 4 h in both men and women whereas meal-derived fatty acid appearance in plasma tended to be greater in men than in women(Reference Jensen101). Postprandial lipaemia and the organ distribution and metabolic fate of NEFA entering the systemic circulation from adipose tissue lipolysis and meals are markedly different in men and pre-menopausal women. After an overnight fast, a smaller proportion of plasma NEFA flux is oxidised to CO2 in women than in men(Reference Koutsari, Basu and Rizza102), even though women convert plasma NEFA more rapidly to readily oxidised ketones(Reference Marinou, Adiels and Hodson103). The greater non-oxidative disposal of NEFA in women appears to be targeted to adipose tissue because a greater proportion of both plasma NEFA and meal-derived fatty acids are stored in subcutaneous adipose tissue in women than in men (about 25 v. ≤10 %, respectively) whereas uptake into liver, muscle and visceral fat after mixed or high fat meal ingestion is not different in men and women(Reference Santosa, Hensrud and Votruba104Reference Votruba and Jensen108). The postprandial increase in plasma TAG after consuming a mixed or high fat meal is less in women than in men, even though the same amount of meal fat is oxidised in women and men(Reference Votruba and Jensen108Reference Pramfalk, Pavlides and Banerjee110) and less meal fat is cleared by splanchnic tissues in women than in men(Reference Nguyen, Hernandez Mijares and Johnson111). The difference in postprandial lipaemia between women and men was observed regardless of whether or not the meal was adjusted for individual subject's energy needs and therefore smaller relative to body weight in men than women. These results suggest markedly impaired peripheral TAG clearance after meal intake in men compared with women. In addition, it was found that adding carbohydrates to an oral lipid load decreased postprandial lipaemia in women but not in men(Reference Knuth, Remias and Horowitz112). The differences in postprandial lipid metabolism in men and pre-menopausal women are at least in part due to differences in the sex hormone milieu(Reference Westerveld, Kock and van Rijn113Reference van Beek, de Ruijter-Heijstek and Erkelens115). However, an independent effect of chronological age on postprandial lipaemia has also been observed and it was as pronounced, if not more pronounced than that of menopause(Reference Jackson, Abraham and Smith25). Moreover, subcutaneous adipose tissue fatty acid storage is even greater in postmenopausal than premenopausal women(Reference Santosa and Jensen116), suggesting the observed sexual dimorphism in adipose tissue fatty acid storage is not due to differences in female sex steroids.

Basal hepatic lipid metabolism in men and women

In a series of studies, we evaluated VLDL-TAG and VLDL-Apo-B-100 kinetics by using stable isotope labelled tracer techniques in conjunction with compartmental modelling analysis in lean and obese men and women. The results from these studies revealed that a person's sex affects the kinetics of both the particle (Apo-B-100) per se and the TAG moiety of particles, often independently suggesting differences in the lipid load of particles. The differences between men and women are not only due to differences in the sex hormone milieu and are dependent on subjects' adiposity status. We found: (i) lean young women produce fewer but TAG-richer VLDL particles than men(Reference Mittendorfer, Yoshino and Patterson69,Reference Magkos, Patterson and Mohammed72,Reference Mittendorfer, Patterson and Klein117) , (ii) ovarian hormone deficiency after menopause increases VLDL-TAG but not VLDL-Apo-B-100 (VLDL particle) secretion rate(Reference Magkos, Fabbrini and Mohammed118), (iii) testosterone treatment has no effect on VLDL-TAG and VLDL-Apo-B-100 kinetics, but oestradiol given to postmenopausal women with obesity stimulates VLDL-TAG plasma clearance(Reference Wang, Smith and Patterson119,Reference Smith, Reeds and Okunade120) , (iv) increased VLDL-TAG concentrations in obese compared with lean men results from over-secretion of VLDL-TAG whereas increased VLDL-TAG concentrations in obese compared with lean women results in part from VLDL-TAG over-secretion but mostly from impaired VLDL-TAG removal from plasma(Reference Mittendorfer, Yoshino and Patterson69,Reference Mittendorfer, Patterson and Klein117) and (v) obese women, but not obese men, are resistant to the inhibitory effects of combined hyperglycaemia–hyperinsulinaemia on hepatic VLDL-TAG secretion whereas no differences in the hyperglycaemia–hyperinsulinaemia induced suppression of VLDL-TAG secretion was observed in lean men and women(Reference Mittendorfer, Patterson and Klein121). A higher VLDL-TAG secretion rate in women with abdominal obesity compared with lean women was also observed by others(Reference Hodson, Banerjee and Rial122) and was mostly due to an increase in the secretion of large and to a lesser extent small VLDL (50 and 12 % increase, respectively). The VLDL-TAG plasma clearance rate in that study was also about 15–20 % less in obese compared with lean women, but the difference did not reach statistical significance(Reference Hodson, Banerjee and Rial122). In addition, it was found that menopause increased hepatic TAG secretion specifically in the small VLDL fraction, and decreased or tended to decrease the secretion of both small and large VLDL particles(Reference Hodson, Banerjee and Rial122). The observed differences in the VLDL-TAG secretion rate between men and women are most likely due to differences in the incorporation of systemic plasma fatty acids into VLDL-TAG(Reference Magkos, Patterson and Mohammed72), rather than differences in hepatic DNL(Reference Pramfalk, Pavlides and Banerjee110).

Effect of fructose ingestion on hepatic de novo lipogenesis in men and women

Fructose stimulates hepatic DNL and high fructose consumption is associated with hepatic steatosis and hypertriglyceridaemia(Reference Pinnick and Hodson123Reference Schwarz, Noworolski and Erkin-Cakmak125). Consumption of a high- compared with a low-fructose drink (containing 100 g sugar with either 60 or 20 % fructose) significantly increased postprandial hepatic DNL in women (peak DNL about 20 % v. about 7 %) but not in men (about 7 % after both meals)(Reference Low, Cornfield and Charlton126). This suggests women are more susceptible to fructose-induced hepatic steatosis and non-alcoholic fatty liver disease. It is worth noting that the stimulatory effect of fructose on DNL is most likely a secondary phenomenon because very little fructose is directly converted to fatty acids and fructose-to-fatty acid conversion was only observed in men but not in women(Reference Tran, Jacot-Descombes and Lecoultre65). This is consistent with recent findings that suggest fructose metabolism occurs predominantly in the small intestine, where it is converted to glucose, lactate and glycerol(Reference Jang, Hui and Lu127).

Myocardial substrate utilisation in men and women

A series of elegant studies that used dynamic positron emission tomography imaging have demonstrated marked differences in myocardial substrate use in men and women. Myocardial oxygen consumption is greater in healthy lean women than healthy lean men and women's hearts use less glucose and fewer dietary fatty acids as a source of energy than men(Reference Kunach, Noll and Phoenix106,Reference Peterson, Soto and Herrero128,Reference Peterson, Herrero and Coggan129) . Obesity reduces myocardial glucose uptake and oxidation in men, but not in women(Reference Peterson, Herrero and Coggan129). Insulin-stimulated myocardial glucose uptake rate, conversely, is not different in healthy young men and women(Reference Nuutila, Knuuti and Maki83). These findings could have important clinical implications, because myocardial perfusion and fuel use are directly linked with cardiac function(Reference Mather and DeGrado130,Reference Abel, O'Shea and Ramasamy131) .

Conclusion

There are marked differences in many aspects of glucose and lipid metabolism in men and women. Women compared with men: (i) are more sensitive to the inhibitory effect of insulin on glucose production and the stimulatory effect of insulin on muscle glucose disposal, (ii) have greater adipose tissue NEFA release relative to fat-free mass and resting energy and are less susceptible to the adverse effect of NEFA on insulin action in muscle, (iii) have altered meal glucose absorption kinetics, possibly due to different gastric emptying rates(Reference Hutson, Roehrkasse and Wald132), (iv) have greater basal and postprandial non-oxidative fatty acid disposal and fatty acid storage in adipose tissue and reduced postprandial lipaemia and (v) are more susceptible to fructose-induced DNL. Moreover, hepatic and plasma lipid metabolism is markedly affected by sex and the observed metabolic differences between men and women depend on subjects' adiposity and age. Conversely, no major differences between men and women have been observed for the antilipolytic effect of insulin and acute glucose-induced insulin secretion. The effect of sex on plasma insulin clearance is unclear because of conflicting results from different studies. We conclude that sex needs to be considered when interpreting data reported in the literature and planning new studies. Carefully designed studies are needed to determine the mechanisms responsible for the observed sexual dimorphism in metabolism and to disentangle the effects of chronological and biological (pre/post menopause) age on metabolism in women.

Financial Support

The authors received salary support from NIH grants DK115400, DK121560, DK56341 (Washington University School of Medicine Nutrition and Obesity Research Center), and UL1 TR000448 (Washington University School of Medicine Clinical Translational Science Award), a grant from the American Diabetes Association (ICTS 1-18-ICTS-119) and the Atkins Obesity Award while working on this manuscript.

Conflict of Interest

None.

Authorship

The authors were jointly responsible for all aspects of preparation of this paper.

References

1.Collaborators GBDCoD (2018) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 17361788.CrossRefGoogle Scholar
2.Laslett, LJ, Alagona, P Jr, Clark, BA III et al. (2012) The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol 60, Suppl. 25, S149.CrossRefGoogle ScholarPubMed
3.Blackwell, D & Villarroel, M (2018) Summary Health Statistics for U.S. Adults: 2017 National Health Interview Survey. National Center for Health Statistics.Google Scholar
4.Klein, S, Wadden, T & Sugerman, HJ (2002) AGA technical review on obesity. Gastroenterology 123, 882932.CrossRefGoogle ScholarPubMed
5.Castelli, WP (1988) Cholesterol and lipids in the risk of coronary artery disease – the Framingham Heart Study. Can J Cardiol 4, Suppl. A, 5A10A.Google ScholarPubMed
6.Jeppesen, J, Hein, HO, Suadicani, P et al. (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97, 10291036.CrossRefGoogle ScholarPubMed
7.Abdel-Maksoud, MF, Eckel, RH, Hamman, RF et al. (2012) Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men. J Clin Lipidol 6, 374381.CrossRefGoogle ScholarPubMed
8.Ference, BA, Kastelein, JJP, Ray, KK et al. (2019) Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA 321, 364373.CrossRefGoogle ScholarPubMed
9.Levitan, EB, Song, Y, Ford, ES et al. (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Int Med 164, 21472155.CrossRefGoogle ScholarPubMed
10.Kannel, WB & McGee, DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 20352038.CrossRefGoogle ScholarPubMed
11.Kolovou, GD, Watts, GF, Mikhailidis, DP et al. (2019) Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 Expert Panel statement. Curr Vasc Pharmacol (In the Press).Google ScholarPubMed
12.Wei, M, Gaskill, SP, Haffner, SM et al. (1998) Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21, 11671172.CrossRefGoogle ScholarPubMed
13.Nordestgaard, BG, Benn, M, Schnohr, P et al. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299308.CrossRefGoogle ScholarPubMed
14.Laakso, M & Kuusisto, J (2014) Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 10, 293302.CrossRefGoogle ScholarPubMed
15.Reusch, JE & Wang, CC (2011) Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab 96, 23672376.CrossRefGoogle ScholarPubMed
16.Miller, M, Stone, NJ, Ballantyne, C et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 22922333.CrossRefGoogle ScholarPubMed
17.Menke, A, Rust, KF, Savage, PJ et al. (2014) Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in U.S. population subgroups: NHANES 2005–2010. Ann Epidemiol 24, 8389.CrossRefGoogle ScholarPubMed
18.Anderwald, C, Gastaldelli, A, Tura, A et al. (2011) Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab 96, 515524.CrossRefGoogle ScholarPubMed
19.Magkos, F, Mohammed, BS & Mittendorfer, B (2008) Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int J Obes 32, 16551664.CrossRefGoogle ScholarPubMed
20.Faerch, K, Borch-Johnsen, K, Vaag, A et al. (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53, 858865.CrossRefGoogle ScholarPubMed
21.Clausen, JO, Borch-Johnsen, K, Ibsen, H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98, 11951209.CrossRefGoogle Scholar
22.Flanagan, DE, Holt, RI, Owens, PC et al. (2006) Gender differences in the insulin-like growth factor axis response to a glucose load. Acta Physiol 187, 371378.CrossRefGoogle ScholarPubMed
23.Pascot, A, Lemieux, I, Bergeron, J et al. (2002) HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis 160, 399406.CrossRefGoogle ScholarPubMed
24.Wang, X, Magkos, F & Mittendorfer, B (2011) Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab 96, 885893.CrossRefGoogle Scholar
25.Jackson, KG, Abraham, EC, Smith, AM et al. (2010) Impact of age and menopausal status on the postprandial triacylglycerol response in healthy women. Atherosclerosis 208, 246252.CrossRefGoogle ScholarPubMed
26.Tsai, SS, Lin, YS, Hwang, JS et al. (2017) Vital roles of age and metabolic syndrome-associated risk factors in sex-specific arterial stiffness across nearly lifelong ages: Possible implication of menopause and andropause. Atherosclerosis 258, 2633.CrossRefGoogle ScholarPubMed
27.Anagnostis, P, Stevenson, JC, Crook, D et al. (2016) Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clin Endocrinol 85, 733740.CrossRefGoogle ScholarPubMed
28.Matthews, KA, Crawford, SL, Chae, CU et al. (2009) Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54, 23662373.CrossRefGoogle ScholarPubMed
29.Peters, SA, Huxley, RR & Woodward, M (2014) Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57, 15421551.CrossRefGoogle ScholarPubMed
30.Kalyani, RR, Lazo, M, Ouyang, P et al. (2014) Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care 37, 830838.CrossRefGoogle Scholar
31.Skaug, EA, Madssen, E, Aspenes, ST et al. (2014) Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study. PLoS One 9, e101371.CrossRefGoogle ScholarPubMed
32.Caviezel, S, Dratva, J, Schaffner, E et al. (2014) Sex-specific associations of cardiovascular risk factors with carotid stiffness – results from the SAPALDIA cohort study. Atherosclerosis 235, 576584.CrossRefGoogle ScholarPubMed
33.Sone, H, Tanaka, S, Tanaka, S et al. (2012) Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care 35, 11501157.CrossRefGoogle ScholarPubMed
34.Stock, J (2019) Triglycerides and cardiovascular risk: apolipoprotein B holds the key. Atherosclerosis 284, 221222.CrossRefGoogle ScholarPubMed
35.Navar, AM (2019) The evolving story of triglycerides and coronary heart disease risk. JAMA 321, 347349.CrossRefGoogle ScholarPubMed
36.Manco, M, Nolfe, G, Pataky, Z et al. (2017) Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort. Metabolism 70, 4250.CrossRefGoogle ScholarPubMed
37.Abdul-Ghani, MA, Lyssenko, V, Tuomi, T et al. (2010) The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev 26, 280286.CrossRefGoogle ScholarPubMed
38.Hulman, A, Simmons, RK, Vistisen, D et al. (2017) Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine 55, 427434.CrossRefGoogle ScholarPubMed
39.Vistisen, D, Witte, DR, Tabak, AG et al. (2014) Sex differences in glucose and insulin trajectories prior to diabetes diagnosis: the Whitehall II study. Acta Diabetol 51, 315319.CrossRefGoogle ScholarPubMed
40.Trico, D, Natali, A, Arslanian, S et al. (2018) Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents. JCI Insight 3, pii: 124912.CrossRefGoogle ScholarPubMed
41.Petersen, MC & Shulman, GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98, 21332223.CrossRefGoogle ScholarPubMed
42.Samuel, VT & Shulman, GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126, 1222.CrossRefGoogle ScholarPubMed
43.Petersen, MC, Vatner, DF & Shulman, GI (2017) Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 13, 572587.CrossRefGoogle ScholarPubMed
44.Kolterman, OG, Insel, J, Saekow, M et al. (1980) Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 65, 12721284.CrossRefGoogle ScholarPubMed
45.Conte, C, Fabbrini, E, Kars, M et al. (2012) Multiorgan insulin sensitivity in lean and obese subjects. Diabetes Care 35, 13161321.CrossRefGoogle ScholarPubMed
46.Rizza, RA, Mandarino, LJ & Gerich, JE (1981) Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240, E630E639.Google ScholarPubMed
47.Jensen, MD & Nielsen, S (2007) Insulin dose response analysis of free fatty acid kinetics. Metabolism 56, 6876.CrossRefGoogle ScholarPubMed
48.Jensen, MD, Caruso, M, Heiling, V et al. (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38, 15951601.CrossRefGoogle ScholarPubMed
49.Sparks, JD, Sparks, CE & Adeli, K (2012) Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 32, 21042112.CrossRefGoogle ScholarPubMed
50.Kim, SH & Reaven, GM (2016) Insulin clearance: an underappreciated modulator of plasma insulin concentration. J Investig Med 64, 11621165.CrossRefGoogle ScholarPubMed
51.Rudovich, NN, Rochlitz, HJ & Pfeiffer, AF (2004) Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53, 23592365.CrossRefGoogle ScholarPubMed
52.Kahn, SE, Prigeon, RL, McCulloch, DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42, 16631672.CrossRefGoogle ScholarPubMed
53.Arner, P & Ryden, M (2015) Fatty acids, obesity and insulin resistance. Obes Facts 8, 147155.CrossRefGoogle ScholarPubMed
54.Hoeg, LD, Sjoberg, KA, Jeppesen, J et al. (2011) Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 60, 6473.CrossRefGoogle ScholarPubMed
55.Mittendorfer, B, Horowitz, JF & Klein, S (2001) Gender differences in lipid and glucose kinetics during short-term fasting. Am J Physiol Endocrinol Metab 281, E1333E1339.CrossRefGoogle ScholarPubMed
56.Henderson, GC, Fattor, JA, Horning, MA et al. (2008) Glucoregulation is more precise in women than in men during postexercise recovery. Am J Clin Nutr 87, 16861694.CrossRefGoogle ScholarPubMed
57.Ter Horst, KW, Gilijamse, PW, de Weijer, BA et al. (2015) Sexual dimorphism in hepatic, adipose tissue, and peripheral tissue insulin sensitivity in obese humans. Front Endocrinol 6, 182.CrossRefGoogle ScholarPubMed
58.Frias, JP, Macaraeg, GB, Ofrecio, J et al. (2001) Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 50, 13441350.CrossRefGoogle ScholarPubMed
59.Marliss, EB, Kreisman, SH, Manzon, A et al. (2000) Gender differences in glucoregulatory responses to intense exercise. J Appl Physiol 88, 457466.CrossRefGoogle ScholarPubMed
60.Carter, SL, Rennie, C & Tarnopolsky, MA (2001) Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 280, E898E907.CrossRefGoogle ScholarPubMed
61.Perreault, L, Bergman, BC, Hunerdosse, DM et al. (2010) Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes. Obesity 18, 20932100.CrossRefGoogle Scholar
62.Yeo, SE, Hays, NP, Dennis, RA et al. (2007) Fat distribution and glucose metabolism in older, obese men and women. J Gerontol A Biol Sci Med Sci 62, 13931401.CrossRefGoogle ScholarPubMed
63.Honka, MJ, Latva-Rasku, A, Bucci, M et al. (2018) Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study. Eur J Endocrinol 178, 523531.CrossRefGoogle ScholarPubMed
64.Basu, R, Dalla Man, C, Campioni, M et al. (2006) Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55, 20012014.CrossRefGoogle ScholarPubMed
65.Tran, C, Jacot-Descombes, D, Lecoultre, V et al. (2010) Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load. Br J Nutr 104, 11391147.CrossRefGoogle ScholarPubMed
66.Soeters, MR, Sauerwein, HP, Groener, JE et al. (2007) Gender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab 92, 36463652.CrossRefGoogle Scholar
67.Karpe, F, Dickmann, JR & Frayn, KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60, 24412449.CrossRefGoogle Scholar
68.Mittendorfer, B, Magkos, F, Fabbrini, E et al. (2009) Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity 17, 18721877.CrossRefGoogle ScholarPubMed
69.Mittendorfer, B, Yoshino, M, Patterson, BW et al. (2016) VLDL triglyceride kinetics in lean, overweight, and obese men and women. J Clin Endocrinol Metab 101, 41514160.CrossRefGoogle ScholarPubMed
70.Mittendorfer, B, Liem, O, Patterson, BW et al. (2003) What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 52, 16411648.CrossRefGoogle ScholarPubMed
71.Nielsen, S, Guo, Z, Albu, JB et al. (2003) Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 111, 981988.CrossRefGoogle ScholarPubMed
72.Magkos, F, Patterson, BW, Mohammed, BS et al. (2007) Women produce fewer but triglyceride-richer very low density lipoproteins than men. J Clin Endocrinol Metab 92, 13111318.CrossRefGoogle ScholarPubMed
73.Gallagher, D, Heymsfield, SB, Heo, M et al. (2000) Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72, 694701.CrossRefGoogle ScholarPubMed
74.Oshima, S, Miyauchi, S, Kawano, H et al. (2011) Fat-free mass can be utilized to assess resting energy expenditure for male athletes of different body size. J Nutr Sci Vitaminol 57, 394400.CrossRefGoogle ScholarPubMed
75.Cunningham, JJ (1991) Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 54, 963969.CrossRefGoogle Scholar
76.Guerra, B, Fuentes, T, Delgado-Guerra, S et al. (2008) Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One 3, e3466.CrossRefGoogle ScholarPubMed
77.Sung, KC, Choi, JH, Gwon, HC et al. (2013) Relationship between insulin resistance and coronary artery calcium in young men and women. PLoS One 8, e53316.CrossRefGoogle ScholarPubMed
78.Sumner, AE, Kushner, H, Sherif, KD et al. (1999) Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Diabetes Care 22, 7177.CrossRefGoogle ScholarPubMed
79.Faerch, K, Pacini, G, Nolan, JJ et al. (2013) Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs. Diabetes Care 36, 36913697.CrossRefGoogle ScholarPubMed
80.Chan, Z, Chooi, YC, Ding, C et al. (2019) Sex differences in glucose and fatty acid metabolism in Asians who are nonobese. J Clin Endocrinol Metab 104, 127136.CrossRefGoogle ScholarPubMed
81.Boirie, Y, Gachon, P, Cordat, N et al. (2001) Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 86, 638644.CrossRefGoogle ScholarPubMed
82.Hoeg, L, Roepstorff, C, Thiele, M et al. (2009) Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling. J Appl Physiol 107, 824831.CrossRefGoogle Scholar
83.Nuutila, P, Knuuti, MJ, Maki, M et al. (1995) Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44, 3136.CrossRefGoogle ScholarPubMed
84.Rathmann, W, Strassburger, K, Giani, G et al. (2008) Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabetic Med 25, 13741375.Google ScholarPubMed
85.Sicree, RA, Zimmet, PZ, Dunstan, DW et al. (2008) Differences in height explain gender differences in the response to the oral glucose tolerance test – the AusDiab study. Diabetic Med 25, 296302.CrossRefGoogle ScholarPubMed
86.DeFronzo, RA, Jacot, E, Jequier, E et al. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 10001007.CrossRefGoogle ScholarPubMed
87.Yki-Jarvinen, H, Young, AA, Lamkin, C et al. (1987) Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79, 17131719.CrossRefGoogle ScholarPubMed
88.Dadson, P, Landini, L, Helmio, M et al. (2016) Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes. Diabetes Care 39, 292299.Google ScholarPubMed
89.Goodpaster, BH, Bertoldo, A, Ng, JM et al. (2014) Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 diabetes: studies with dynamic PET imaging. Diabetes 63, 10581068.CrossRefGoogle ScholarPubMed
90.Williams, KV, Price, JC & Kelley, DE (2001) Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. Diabetes 50, 20692079.CrossRefGoogle ScholarPubMed
91.Boden, G, Chen, X, Ruiz, J et al. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93, 24382446.CrossRefGoogle ScholarPubMed
92.Lee, KU, Lee, HK, Koh, CS et al. (1988) Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31, 285290.Google ScholarPubMed
93.Shah, P, Vella, A, Basu, A et al. (2002) Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 51, 301310.CrossRefGoogle ScholarPubMed
94.Belfort, R, Mandarino, L, Kashyap, S et al. (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 16401648.CrossRefGoogle ScholarPubMed
95.Gormsen, LC, Nielsen, C, Jessen, N et al. (2011) Time-course effects of physiological free fatty acid surges on insulin sensitivity in humans. Acta Physiol 201, 349356.CrossRefGoogle ScholarPubMed
96.Vistisen, B, Hellgren, LI, Vadset, T et al. (2008) Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol 158, 6168.CrossRefGoogle ScholarPubMed
97.Shadid, S, Kanaley, JA, Sheehan, MT et al. (2007) Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab 292, E17704.CrossRefGoogle ScholarPubMed
98.Millstein, RJ, Pyle, LL, Bergman, BC et al. (2018) Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 32, 418423.CrossRefGoogle ScholarPubMed
99.Jensen, MD, Nielsen, S, Gupta, N et al. (2012) Insulin clearance is different in men and women. Metabolism 61, 525530.CrossRefGoogle ScholarPubMed
100.Waldhausl, WK, Gasic, S, Bratusch-Marrain, P et al. (1982) Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. Am J Physiol 243, E476E482.Google ScholarPubMed
101.Jensen, MD (1995) Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest 96, 22972303.CrossRefGoogle ScholarPubMed
102.Koutsari, C, Basu, R, Rizza, RA et al. (2011) Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab 96, 541547.CrossRefGoogle ScholarPubMed
103.Marinou, K, Adiels, M, Hodson, L et al. (2011) Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br J Nutr 105, 857865.CrossRefGoogle ScholarPubMed
104.Santosa, S, Hensrud, DD, Votruba, SB et al. (2008) The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am J Clin Nutr 88, 11341141.CrossRefGoogle ScholarPubMed
105.Koutsari, C, Snozek, CL & Jensen, MD (2008) Plasma NEFA storage in adipose tissue in the postprandial state: sex-related and regional differences. Diabetologia 51, 20412048.CrossRefGoogle ScholarPubMed
106.Kunach, M, Noll, C, Phoenix, S et al. (2015) Effect of sex and impaired glucose tolerance on organ-specific dietary fatty acid metabolism in humans. Diabetes 64, 24322441.CrossRefGoogle ScholarPubMed
107.Romanski, SA, Nelson, RM & Jensen, MD (2000) Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab 279, E455E462.CrossRefGoogle ScholarPubMed
108.Votruba, SB & Jensen, MD (2006) Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab 291, E1115E1123.CrossRefGoogle ScholarPubMed
109.Knuth, ND & Horowitz, JF (2006) The elevation of ingested lipids within plasma chylomicrons is prolonged in men compared with women. J Nutr 136, 14981503.CrossRefGoogle Scholar
110.Pramfalk, C, Pavlides, M, Banerjee, R et al. (2015) Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men. J Clin Endocrinol Metab 100, 44254433.CrossRefGoogle ScholarPubMed
111.Nguyen, TT, Hernandez Mijares, A, Johnson, CM et al. (1996) Postprandial leg and splanchnic fatty acid metabolism in nonobese men and women. Am J Physiol 271, 6 Pt 1, E965E972.Google ScholarPubMed
112.Knuth, ND, Remias, DB & Horowitz, JF (2008) Adding carbohydrate to a high-fat meal blunts postprandial lipemia in women and reduces meal-derived fatty acids in systemic circulation. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme 33, 315325.CrossRefGoogle ScholarPubMed
113.Westerveld, HT, Kock, LA, van Rijn, HJ et al. (1995) 17 beta-estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 80, 249253.Google ScholarPubMed
114.Iverius, PH & Brunzell, JD (1988) Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. J Clin Invest 82, 11061112.CrossRefGoogle ScholarPubMed
115.van Beek, AP, de Ruijter-Heijstek, FC, Erkelens, DW et al. (1999) Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 19, 27372741.CrossRefGoogle ScholarPubMed
116.Santosa, S & Jensen, MD (2013) Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women. Diabetes 62, 775782.CrossRefGoogle ScholarPubMed
117.Mittendorfer, B, Patterson, BW & Klein, S (2003) Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 77, 573579.CrossRefGoogle ScholarPubMed
118.Magkos, F, Fabbrini, E, Mohammed, BS et al. (2010) Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype. J Clin Endocrinol Metab 95, 33773384.CrossRefGoogle Scholar
119.Wang, X, Smith, GI, Patterson, BW et al. (2012) Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab 302, E740E746.CrossRefGoogle Scholar
120.Smith, GI, Reeds, DN, Okunade, AL et al. (2014) Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women. J Clin Endocrinol Metab 99, E1306E1310.CrossRefGoogle ScholarPubMed
121.Mittendorfer, B, Patterson, BW, Klein, S et al. (2003) VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab 284, E708E715.CrossRefGoogle ScholarPubMed
122.Hodson, L, Banerjee, R, Rial, B et al. (2015) Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women. J Am Heart Assoc 4, e002258.CrossRefGoogle ScholarPubMed
123.Pinnick, KE & Hodson, L. (2019) Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. J Physiol. (In the Press).Google Scholar
124.Le, KA, Faeh, D, Stettler, R et al. (2008) Effects of four-week high-fructose diet on gene expression in skeletal muscle of healthy men. Diabetes Metab 34, 8285.CrossRefGoogle ScholarPubMed
125.Schwarz, JM, Noworolski, SM, Erkin-Cakmak, A et al. (2017) Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology 153, 743752.CrossRefGoogle ScholarPubMed
126.Low, WS, Cornfield, T, Charlton, CA et al. (2018) Sex differences in hepatic de novo lipogenesis with acute fructose feeding. Nutrients 10.CrossRefGoogle ScholarPubMed
127.Jang, C, Hui, S, Lu, W et al. (2018) The small intestine converts dietary fructose into glucose and organic acids. Cell Metab 27, 351361, e3.CrossRefGoogle ScholarPubMed
128.Peterson, LR, Soto, PF, Herrero, P et al. (2007) Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14, 573581.CrossRefGoogle ScholarPubMed
129.Peterson, LR, Herrero, P, Coggan, AR et al. (2015) Type 2 diabetes, obesity, and sex difference affect the fate of glucose in the human heart. Am J Physiol Heart Circ Physiol 308, H15106.CrossRefGoogle ScholarPubMed
130.Mather, KJ & DeGrado, TR (2016) Imaging of myocardial fatty acid oxidation. Biochim Biophys Acta 1861, 15351543.CrossRefGoogle ScholarPubMed
131.Abel, ED, O'Shea, KM & Ramasamy, R (2012) Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler Thromb Vasc Biol 32, 20682076.CrossRefGoogle ScholarPubMed
132.Hutson, WR, Roehrkasse, RL & Wald, A (1989) Influence of gender and menopause on gastric emptying and motility. Gastroenterology 96, 1117.CrossRefGoogle ScholarPubMed